Gut Dysbiosis in Pancreatic Diseases: A Causative Factor and a Novel Therapeutic Target [PDF]
Frontiers in Nutrition, 2022 Pancreatic-related disorders such as pancreatitis, pancreatic cancer, and type 1 diabetes mellitus (T1DM) impose a substantial challenge to human health and wellbeing. Even though our understanding of the initiation and progression of pancreatic diseases
Tao Zhang +14 more
doaj +3 more sources
Nutritional Support in Pancreatic Diseases. [PDF]
Nutrients, 2022 This review summarizes the main pancreatic diseases from a nutritional approach. Nutrition is a cornerstone of pancreatic disease and is sometimes undervalued.
Cañamares-Orbís P +2 more
europepmc +2 more sources
Understanding Necroptosis in Pancreatic Diseases. [PDF]
Biomolecules, 2022 Intermediate between apoptosis and necrosis, necroptosis is a regulated caspase-independent programmed cell death that induces an inflammatory response and mediates cancer development.
He R, Wang Z, Dong S, Chen Z, Zhou W.
europepmc +2 more sources
Ameliorative Effects of Gut Microbial Metabolite Urolithin A on Pancreatic Diseases. [PDF]
Nutrients, 2022 Urolithin A (Uro A) is a dietary metabolite of the intestinal microbiota following the ingestion of plant-based food ingredients ellagitannins and ellagic acid in mammals.
Li K +7 more
europepmc +2 more sources
Microbiota in Pancreatic Diseases: A Review of the Literature. [PDF]
J Clin Med, 2021 The gut microbiota is a critical element in the balance between human health and disease. Its impairment, defined as dysbiosis, is associated with gastroenterological and systemic diseases.
Schepis T +10 more
europepmc +2 more sources
The role of pancreatic polypeptide in pancreatic diseases [PDF]
Advances in Clinical and Experimental Medicine, 2017 The aim of this study was to review the diagnostic significance of pancreatic polypeptide (PP) in pancreatic diseases. PP may play a significant role in monitoring the development of the disease and the patient's healing process, particularly after the removal of a portion of the pancreas. Determining PP in acute pancreatitis is quite controversial. At
Grzegorz Marek +2 more
openaire +4 more sources
Distinguishing diabetes secondary to pancreatic diseases from type 2 diabetes mellitus. [PDF]
Curr Opin Gastroenterol, 2021 Purpose of review Diabetes secondary to pancreatic diseases (i.e., acute pancreatitis, chronic pancreatitis, and pancreatic cancer) is increasingly studied, but remains challenging to distinguish from type 2 diabetes (T2DM).
Hart PA +3 more
europepmc +2 more sources
Artificial intelligence for the management of pancreatic diseases. [PDF]
Dig Endosc, 2021 Novel artificial intelligence techniques are emerging in all fields of healthcare, including gastroenterology. The aim of this review is to give an overview of artificial intelligence applications in the management of pancreatic diseases.
Gorris M +3 more
europepmc +2 more sources
Burden and Cost of Gastrointestinal, Liver, and Pancreatic Diseases in the United States: Update 2021. [PDF]
Gastroenterology, 2022 BACKGROUND Gastrointestinal diseases account for considerable health care use and expenditures. We estimated the annual burden, costs, and research funding associated with gastrointestinal, liver, and pancreatic diseases in the United States.
Peery AF +13 more
europepmc +2 more sources
Cutaneous Manifestations in Pancreatic Diseases-A Review. [PDF]
J Clin Med, 2020 Pancreatic pathology, comprising acute and chronic pancreatitis, autoimmune pancreatitis and pancreatic neoplasms, primarily presents with gastrointestinal symptoms and signs; however, it is well recognized that it can also associate a wide range of ...
Miulescu R +3 more
europepmc +2 more sources